IPO Boutique Research, Color & More Information for Subscribers
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
This past week 10 secondary offerings came to market and IPO Boutique placed BUY ratings on 6 of them. This week, $1.33bn was raised by companies in the secondary market. You can Subscribe to IPO Boutique’s Secondary Only Service by clicking here: The average gain of BUY rated offerings this week at first trade was[…]
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Proteostasis Therapeutics Symbol: PTI Price: Last trade $15.24 Trade Date: 9/9 Shares: 4.25 million Underwriter(s)Leerink Partners, RBC Capital Markets, H.C. Wainwright[…]
It was a second straight month with a strong number of IPOs that came to market as the month of June saw a total of 27 deals price–the most in a single month thus far in 2015. While that number is large and indeed caused angst among investors and media-talking-heads alike, it is not entirely[…]
This past week four IPOs debuted, five updated terms and five new deals were filed. Channel checks indicated each of the deals this week had considerable strength with two of the four deals pricing above range. The deal of the week, DAVIDsTea (Nasdaq: DTEA) priced ($19.00) above an already upwardly revised range and opened at[…]